Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the efficacy of 3 multiple doses of VIT-2763 as
measured by the reduction in red blood cell (RBC) transfusion burden from Week 13 to Week 24,
to identify the most efficacious and safe dose.